Recombinant hGH Discovery Study of biomarkers indicative of exposure to recombinant growth hormone

Trial Profile

Recombinant hGH Discovery Study of biomarkers indicative of exposure to recombinant growth hormone

Recruiting
Phase of Trial: Phase I

Latest Information Update: 22 Aug 2014

At a glance

  • Drugs Somatropin (Primary)
  • Indications Short stature; Somatotropin deficiency; Turner's syndrome
  • Focus Biomarker; Pharmacokinetics
  • Acronyms REBIODIS
  • Most Recent Events

    • 22 Aug 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top